May 31, 2010
Otsuka Pharmaceutical Co., Ltd.
Streptococcus pneumoniae Kit "RAPIRUN S. pneumoniae" Approval obtained as in vitro diagnostic on May 26
Otsuka Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) today announced that it obtained manufacturing and marketing approval of the Streptococcus pneumoniae antigen detection reagent by the immunochromatography method, "RAPIRUN S. pneumoniae" as an in vitro diagnostic on May 26, 2010.
Information in this news release was current as of the original release date.